Skip to content

Changes in neuroticism and values after naturalistic use of psychedelics and MDMA: a prospective survey study

Abigail E. Calder, Vincent J. Diehl, Bernd Hinney, Gregor Hasler

Journal of Affective Disorders Reports July 1, 2026 DOI: 10.1016/j.jadr.2026.101127 via OpenAlex

Summary

AI-generated from the abstract

People who planned to use serotonergic psychedelics or MDMA in naturalistic settings reported lower neuroticism four weeks later, with the largest reductions in shame and feelings of tension. One week after use, they rated citizenship, family, intimate relationships, and spirituality as more important; only family remained elevated at four weeks. Serotonergic psychedelics were linked to greater increases in spirituality than MDMA. The findings suggest that both types of substances can produce lasting decreases in neuroticism and transient shifts in personal values, with family values showing the most persistent change.

Study at a glance

Characteristics Prospective observational study Peer reviewed
Sample size 74
Population People planning to use psychedelics or MDMA in naturalistic settings
Duration 4-week follow-up
Keywords Neuroticism Survey research Personality Naturalistic observation Survey data collection
Key finding Planned naturalistic use of psychedelics and MDMA was associated with decreased neuroticism at four weeks and transient increases in the importance of relational and spiritual values, with family values remaining elevated at four weeks.

Abstract

Background Serotonergic psychedelics and MDMA may improve mental health through reductions in neuroticism and changes in personal values. While decreases in neuroticism following serotonergic psychedelics are sometimes observed, it is unclear which facets of neuroticism respond the most, and MDMA remains understudied. People also report value shifts after psychedelic experiences, but prospective data are limited. This study examined changes in neuroticism and twelve personal values after planned, naturalistic use of psychedelics and MDMA. Methods Participants planning to use psychedelics or MDMA (N=74) completed surveys at baseline, one day post-experience, one week, and four weeks follow-up. Neuroticism was assessed with the NEO-FFI and personal values with a modified Valued Living Questionnaire. Linear mixed effects models examined changes over time. Results Neuroticism significantly decreased at four weeks (β=-2.64, p <.001), though not at one week (β=0.01, p =0.99), for users of both serotonergic psychedelics and MDMA. Reductions were most pronounced for items assessing shame and feelings of tension. Participants rated the values of citizenship (β = 0.68, t = 2.63, p = 0.01), family (β = 0.80, t = 3.64, p < .001), intimate relationships (β = 0.57, t = 2.88, p = 0.01), and spirituality (β = 1.04, t = 4.08, p < .001) as more important one week after their psychedelic experience; only family remained elevated at four weeks (β = 0.57, t = 2.41, p = 0.02). Serotonergic psychedelics were associated with greater spirituality increases than MDMA (β = 2.19, t = 4.19, p = .005). Discussion Planned consumption of psychedelics and MDMA in naturalistic settings was associated with decreased neuroticism and transiently increased importance of relational and spiritual values. The increased importance of family persisted longest, lasting up to four weeks. These findings expand the literature on self-reported changes in neuroticism and identify potential mechanisms underlying changes in well-being after psychedelic experiences.

Comments

No comments yet.

Log in to comment